Exploring the uncertainties of early detection results: model-based interpretation of mayo lung project
Open Access
- 7 March 2011
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 11 (1) , 92
Abstract
The Mayo Lung Project (MLP), a randomized controlled clinical trial of lung cancer screening conducted between 1971 and 1986 among male smokers aged 45 or above, demonstrated an increase in lung cancer survival since the time of diagnosis, but no reduction in lung cancer mortality. Whether this result necessarily indicates a lack of mortality benefit for screening remains controversial. A number of hypotheses have been proposed to explain the observed outcome, including over-diagnosis, screening sensitivity, and population heterogeneity (initial difference in lung cancer risks between the two trial arms). This study is intended to provide model-based testing for some of these important arguments.Keywords
This publication has 20 references indexed in Scilit:
- Volunteer effect and compromised randomization in the Mayo Project of screening for lung cancerEuropean Journal of Epidemiology, 2010
- Modeling excess lung cancer risk among screened arm participants in the Mayo Lung ProjectCancer, 2009
- A Clinical Practice Guideline for Treating Tobacco Use and Dependence: 2008 UpdateAmerican Journal of Preventive Medicine, 2008
- Extended Lung Cancer Incidence Follow-up in the Mayo Lung Project and OverdiagnosisJNCI: Journal of the National Cancer Institute, 2006
- Extended Nortriptyline and Psychological Treatment for Cigarette SmokingAmerican Journal of Psychiatry, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Early Lung Cancer Action Project: overall design and findings from baseline screeningThe Lancet, 1999
- Screening for lung cancer: The Mayo lung project revisitedCancer, 1993
- Survival for clinical stage I lung cancer not surgically treated. Comparison between screen-detected and symptom-detected casesCancer, 1992
- The MISCAN simulation program for the evaluation of screening for diseaseComputer Methods and Programs in Biomedicine, 1985